Skip to main content
. 2012 Jul 17;7:3667–3677. doi: 10.2147/IJN.S30428

Figure 9.

Figure 9

Effect of curcumin, curcumin-SLNs, and SLNs on IL-4 and IL-13 expression in BALF collected from OVA-sensitized and OVA-challenged rats.

Notes: BALF was collected 24 hours after the last challenge in the normal saline group (saline), OVA-sensitized and OVA-challenged rats (OVA); OVA-sensitized and OVA-challenged rats + curcumin treatment group (OVA + curcumin); OVA-challenged rats + curcumin-SLNs treatment group (OVA + curcumin-SLNs). The data are expressed as mean ± SEM (n = 8). *Indicates P < 0.05 compared to the OVA group; **Indicates P < 0.01 compared to the OVA group; #indicates P < 0.05 compared to the OVA + curcumin group.

Abbreviations: SLN, solid lipid nanoparticles; IL, interleukin; BALF, bronchoalveolar lavage fluid; OVA, ovalbumin; SEM, standard error of the mean.